Treatment of refractory hemophagocytic lymphohistiocytosis with emapalumab despite severe concurrent infections

Key Points Neutralization of IFN-γ with emapalumab can reverse severe, refractory hemophagocytic lymphohistiocytosis. Neutralizing IFN-γ did not impair control of multiple viral and other infections in a severely ill patient.